Virax Biolabs
VRAX
VRAX
7 hedge funds and large institutions have $990K invested in Virax Biolabs in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, increasing their positions, 1 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Holders
7
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$858K | |
| 2 | +$73.5K | |
| 3 | +$35K | |
| 4 |
Millennium Management
New York
|
+$11K |
| 5 |
Renaissance Technologies
New York
|
+$8K |
Top Sellers
| 1 | -$115K | |
| 2 | -$28K | |
| 3 | -$4.38K | |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
-$2K |